Supernus Pharmaceuticals | Kortsiktig Gjeld

Current Liabilities Endring Dato
Abbott USD 14.02B 329M 2024-03
ANI Pharmaceuticals USD 136.89M 8.59M 2024-03
Aurora Cannabis CAD 107.38M 10.6M 2023-12
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Canopy Growth CAD 234.72M 13.37M 2024-03
Corcept Therapeutics USD 97.2M 7.3M 2024-03
Eisai JPY 277.78B 29.52B 2023-12
Eli Lilly USD 18.6B 3.4B 2024-03
Pacira USD 93.44M 3.94M 2024-03
Perrigo USD 1.55B 31.8M 2024-03
Pfizer USD 40.5B 9.36B 2024-03
Supernus Pharmaceuticals USD 314.55M 24.36M 2024-03
United Therapeutics USD 860.6M 56.2M 2024-03
Xeris Pharmaceuticals USD 73.08M 22.11M 2024-03



Supernus Pharmaceuticals Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.